CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Financial Flexibility Index
CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Financial Flexibility Index of -0.24x as of March 2026. Free cash flow of $-2.76 Million (operating CF $-2.76 Million minus capex $3.00) represents 0% of total liabilities ($11.46 Million). Check CERO financial resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CERo Therapeutics Holdings, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CERo Therapeutics Holdings, Inc. Common Stock across 5 annual periods. See CERo Therapeutics Holdings, Inc. Common (CERO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CERo Therapeutics Holdings, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for CERo Therapeutics Holdings, Inc. Common Stock. For the full company profile including market capitalisation, see CERo Therapeutics Holdings, Inc. Common market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.77x | $-16.08 Million | $-16.08 Million | $9.09 Million | ▼ -147.6% |
| 2024 | -0.71x | $-5.79 Million | $-5.79 Million | $8.10 Million | ▼ -482.4% |
| 2023 | -0.12x | $-5.79 Million | $-5.79 Million | $47.18 Million | ▼ -1130.1% |
| 2022 | -0.01x | $-398.01K | $-1.09 Million | $39.90 Million | ▼ -9.1% |
| 2021 | -0.01x | $-84.54K | $-697.11K | $9.25 Million | — |